Evidence map›Paper›PMID 31911512›Full record

ArticleBMJ open2020

Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data.

Xhyljeta Luta, Christophe Bagnoud, Mark Lambiris, Anne Decollogny, Yves Eggli, Marie-Annick Le Pogam, Pedro Marques-Vidal, Joachim Marti

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Appropriateness of the Prescription and Use of Medicines: An Old Concept but More Relevant than Ever.International journal of environmental research and public health · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xhyljeta LutaCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-5716-4693
Christophe BagnoudGroupe Mutuel, Martigny, Switzerland.
Mark LambirisSwiss Tropical and Public Health Institute, Basel, Switzerland.
Anne DecollognyCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Yves EggliCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Marie-Annick Le PogamCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-1672-3644
Pedro Marques-VidalDepartment of Internal Medicine, Lausanne University Hospital, Lausanne, Vaud, Switzerland.
Joachim MartiCentre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland joachim.marti@unisante.ch.ORCID 0000-0001-5763-3704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to examine the prevalence and determinants of benzodiazepine prescription among older adults in Switzerland, and analyse association with hospitalisation and costs.

designRetrospective analysis of claims data.

settingThe study was conducted in nine cantons in Switzerland.

participantsOlder adults aged 65 years and older enrolled with a large Swiss health insurance company participated in the study. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was prevalence of benzodiazepine prescription. The secondary outcomes were (1) determinants of any benzodiazepine prescription; (2) the association between any prescription and the probability of hospitalisation for trauma and (3) the association between any prescription and total healthcare expenditures.

resultsOverall, 69 005 individuals were included in the study. Approximately 20% of participants had at least one benzodiazepine prescription in 2017. Prescription prevalence increased with age (65-69: 15.9%; 70-74: 18.4%; 75-80: 22.5%; >80: 25.8%) and was higher in women (25.1%) compared with men (14.6%). Enrollees with the highest deductible of Swiss Francs (CHF) 2500 were 70% less likely to receive a prescription than enrollees with the lowest deductible of CHF 300 (adjusted OR=0.29, 95% CI 0.24 to 0.35).Individuals with at least one prescription had a higher probability of hospitalisation for trauma (OR=1.31, 95% CI 1. 20 to 1.1.44), and 70% higher health care expenditures (β=0.72, 95% CI 0. 67 to 0.77). Enrollees in canton Valais were three times more likely to receive a prescription compared to enrollees from canton Aargau (OR=2.84, 95% 2.51 to 3.21).

conclusionsThe proportion of older adults with at least one benzodiazepine prescription is high, as found in the data of one large Swiss health insurance company. These enrollees are more likely to be hospitalised for trauma and have higher healthcare expenditures. Important differences in prescription prevalence across cantons were observed, suggesting potential overuse. Further research is needed to understand the drivers of variation, prescription patterns across providers, and trends over time.

Indexed as

Health ExpendituresAgedAged, 80 and overBenzodiazepinesCross-Sectional StudiesDrug PrescriptionsFemaleHumansIncidenceInsurance Claim ReviewMalePsychotic DisordersRetrospective StudiesSwitzerlandBenzodiazepinesbenzodiazepine useclaims datacostshospitalisationsolder adultsprescription

Identifiers

PMID31911512
PMCPMC6955498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.